Home

Market Capitalization of Jubilant Pharmova Ltd

Image

Jubilant Pharmova Ltd

NSE: JUBLPHARMA

Market Cap

₹ 15478.38 crore

Last updated on: Apr 03, 2025

Key Highlights

  • The Market Cap of Jubilant Pharmova Ltd is ₹ 15478 crore as of 03 Apr 25 .
  • The Latest Trading Price of Jubilant Pharmova Ltd is ₹ 971.65 as of 03 Apr 15:30 .
  • The dividend payouts of Jubilant Pharmova Ltd changed from ₹ 4.5 to ₹ 5 over 6 quarters. This represents a CAGR of 7.28% .
Image

Jubilant Pharmova Ltd

NSE: JUBLPHARMA

Share Price

₹ 971.65

62.05 (6.82%)

stock direction

Last updated on: Apr 03, 2025

Market Price of Jubilant Pharmova Ltd

1M

1Y

3Y

5Y

Monitoring Jubilant Pharmova Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
03 Apr 2025971.65
02 Apr 2025909.6
01 Apr 2025914.4
28 Mar 2025892.7
27 Mar 2025891.75
26 Mar 2025859.55
25 Mar 2025870.55
24 Mar 2025895.7
21 Mar 2025902.55
20 Mar 2025898.55

SWOT Analysis Of Jubilant Pharmova Ltd

Strength

3

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Jubilant Pharmova Ltd

Asset Value vs Market Value of Jubilant Pharmova Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Jubilant Pharmova Ltd

No data available

No data available

Historical P/E Ratio of Jubilant Pharmova Ltd

No data available

* All values are in %

Historical Revenue of Jubilant Pharmova Ltd

No data available

* All values are in crore

Historical EBITDA of Jubilant Pharmova Ltd

No data available

* All values are in crore

Historical Net Profit of Jubilant Pharmova Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Jubilant Pharmova Ltd

No data available

* All values are in

About Jubilant Pharmova Ltd

  • Jubilant Pharmova Limited, (Formerly known as Jubilant Life Sciences Limited), is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.
  • The Company is engaged in pharmaceuticals, contract research and development services and proprietary novel drugs.
  • The pharmaceuticals segment, through wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of Active Pharmaceutical Ingredients (APIs), Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Contract Manufacturing of Sterile Injectables and Non-Sterile Products through 6 US FDA approved manufacturing facilities in India, USA and Canada with a network of over 48 radiopharmacies in the USA. The contract research and development segment provides drug discovery and development services as well as clinical data software and service solutions.

Jubilant Pharmova Ltd News Hub

Jubilant Biosys signs and issues a put option offer to Pierre Fabre Laboratories

Jubilant Biosys Innovative Research Services,, Singapore (JBIRSPL), subsidiary of Jubilant Biosys (J

Read more

16 Aug 24

Volumes soar at Jubilant Pharmova Ltd counter

Firstsource Solutions Ltd, Adani Energy Solutions Ltd, Sapphire Foods India Ltd, Lloyds Metals & Ene

Read more

01 Aug 24

Volumes soar at Jubilant Pharmova Ltd counter

Alembic Pharmaceuticals Ltd, Doms Industries Ltd, EPL Ltd, Anand Rathi Wealth Ltd are among the othe

Read more

09 Sept 24

Jubilant Pharmova Ltd leads gainers in 'A' group

Morepen Laboratories Ltd, La Opala RG Ltd, AGI Greenpac Ltd and Gujarat Alkalies & Chemicals Ltd are

Read more

09 Sept 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Jubilant Pharmova Ltd Market Cap

What is the market cap of Jubilant Pharmova Ltd?

As of April 3, 2025, Jubilant Pharmova Ltd has a market capitalization of ₹15478.38, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Jubilant Pharmova Ltd's market capitalization?

Jubilant Pharmova Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Jubilant Pharmova Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Jubilant Pharmova Ltd's market capitalization change?

Jubilant Pharmova Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions